FDA Clears Test for Detecting HIV Drug-Resistant Mutations
The test may help clinicians tailor HIV therapy for their patients.
HIV/AIDS
Updated Labeling for Efavirenz-Containing Products Warns of Possible Late-Onset Neurotoxicity
The FDA as approved updated labeling for all efavirenz-containing products with additions to the Warnings and Precautions and Adverse Reactions: Postmarketing Experience sections.
HIV Diagnosis Using Rapid Screening Test May Not Be Reliable in HIV Controllers
Diagnosing HIV using rapid screening test may not be reliable in HIV-1 controllers, a rare group of individuals living with HIV who maintain HIV viremia at extremely low or even undetectable levels in the absence of antiretroviral treatment.
Syringe Exchange Program Has Positive Effect on HIV Diagnoses
A syringe exchange program has averted thousands of injection drug use-associated HIV diagnoses over 10 years.
Dolutegravir-Based Therapy Is Noninferior to Continued PI-Based Therapy in HIV
Investigators analyzed the virologic efficacy and metabolic effect of dolutegravir-based therapy combined with NRTIs in substitution of protease inhibitor-based therapy in patients with a history of failure or intolerance to first-line combination ART.
Interprofessional Collaboration Improves Linkage to HIV Testing, Primary Care
A recent study supports the efficacy of interprofessional collaboration in linking patients with HIV to care services.
Increasing HIV Drug Resistance in Newly Diagnosed Infants
Researchers examined the prevalence of HIV drug resistance patterns among HIV-infected infants using 3 nationally representative surveys in South Africa that evaluated the effectiveness of national programs to prevent mother-to-child transmission of HIV.
Tesamorelin May Aid Patients With HIV, Fatty Liver Disease
Tesamorelin reduces liver fat content in patients with HIV and nonalcoholic fatty liver disease.
Low Uptake of Care and Treatment for Infants Who Are HIV Positive
Researchers assessed the characteristics of children who tested positive for HIV diagnosed with HIV infection at the primary healthcare level, across all provinces of South Africa, their attendance at study-specific exit interviews, and their reported uptake of HIV-related care.
An Overview of HIV-Associated Neurocognitive Disorder
Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
Next post in HIV/AIDS
